MAPT and Alzheimer disease: In attempts to treat AD with mesenchymal stem cell transplantation, researchers have discovered numerous effects of the approach, including promoting lysosomal‐autophagic clearance of Aβ and p‐tau aggregates, inducing microglial M2 polarization, reducing MDA levels, enhancing neuronal dendrite growth, and reducing synaptic losses, among others.